Statements (18)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gene therapy
|
| gptkbp:antigen |
mesothelin
|
| gptkbp:clinicalTrialPhase |
Phase 1/2
|
| gptkbp:developedBy |
gptkb:TCR2_Therapeutics
|
| https://www.w3.org/2000/01/rdf-schema#label |
gavo-cel (TC-210)
|
| gptkbp:indication |
gptkb:non-small_cell_lung_cancer
gptkb:cancer mesothelioma cholangiocarcinoma |
| gptkbp:mechanismOfAction |
genetically engineered T cells expressing a mesothelin-targeted TCR fusion construct
|
| gptkbp:otherName |
TC-210
|
| gptkbp:routeOfAdministration |
intravenous
|
| gptkbp:status |
investigational
|
| gptkbp:target |
mesothelin
|
| gptkbp:treatment |
gene therapy
|
| gptkbp:trialIdentifier |
NCT03907852
|
| gptkbp:bfsParent |
gptkb:TCR2_Therapeutics
|
| gptkbp:bfsLayer |
8
|